The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
Open accessAbstract
Soluble Aβ oligomers contribute importantly to synaptotoxicity in Alzheimer's disease, but their dynamics in vivo remain unclear. Here, we found that soluble Aβ oligomers were sequestered from brain interstitial fluid onto brain membranes much more rapidly than nontoxic monomers and were recovered in part as bound to GM1 ganglioside on membranes. Aβ oligomers bound strongly to GM1 ganglioside, and blocking the sialic acid residue on GM1 decreased oligomer-mediated LTP impairment in mouse hippocampal slices. In a hAPP transgenic mouse model, substantial levels of GM1-bound Aβ₄₂ were recovered from brain membrane fractions. We also detected GM1-bound Aβ in human CSF, and its levels correlated with Aβ₄₂, suggesting its potential as a biomarker of Aβ-related membrane dysfunction. Together, these findings highlight a mechanism whereby hydrophobic Aβ oligomers become sequestered onto GM1 ganglioside and presumably other lipids on neuronal membranes, where they may induce progressive functional and structural changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“If so, this could help clarify potential mechanisms behind observations that Ab oligomers, but not monomers, can exert synaptotoxicity (Gong et al., 2003; Klyubin et al., 2005; Lacor et al., 2004; Lambert et al., 1998; Lesné et al., 2006; Shankar et al., 2007, 2008; Walsh et al., 2002), alter tau and other cytoskeleta…”
RetractedTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Self-citationMembrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, É. (2009) · Nature reviews. Immunology · doi:10.1038/nri2567 · Cited by 3,996
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Self-citationDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Flagged first, then by citations
1 of the 72 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Self-citationComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
“This could occur in multiple ways: soluble oAβ associates with synaptic membranes and other synaptic markers (4, 26); thus, oAβ bound to synapses may anchor C1q directly.”
Self-citationImmune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future
Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988
“For example, AβOs bind to sialic acid-containing GM1 ganglioside on cell membrane to induce LTP impairment.(64) On the other hand, cholesterol-rich lipid rafts provide an optimal environment for Aβ synthesis and enhance the interaction of Aβ with the membrane.”
Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00731g · Cited by 576
New insights on the role of microglia in synaptic pruning in health and disease
Hong, S., Dissing-Olesen, L., & Stevens, B. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.12.004 · Cited by 557
Self-citationLipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases
Bartels, T., De Schepper, S., & Hong, S. (2020) · Science · doi:10.1126/science.abb8587 · Cited by 412
Self-citationThe amyloid cascade hypothesis: are we poised for success or failure?
Karran, E., & De Strooper, B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13632 · Cited by 402
Acceleration of α-Synuclein Aggregation by Exosomes
Grey, M., Dunning, C. J. R., Gaspar, R., Grey, C. E., Brundin, P., Sparr, E., & Linse, S. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.585703 · Cited by 383
Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373
Smith, A. J., Yao, X., Dix, J. A., Jin, B.-J., & Verkman, A. S. (2017) · eLife · doi:10.7554/elife.27679 · Cited by 362
Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia
Paolicelli, R. C., Bergamini, G., & Rajendran, L. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.003 · Cited by 338
Yuyama, K., Sun, H., Sakaï, S., Mitsutake, S., Okada, M., Tahara, H., Furukawa, J., Fujitani, N., Shinohara, Y., & Igarashi, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577213 · Cited by 342
β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease
Gouras, G. K., Olsson, T. T., & Hansson, O. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0313-y · Cited by 346
Brain lipidomics: From functional landscape to clinical significance
Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324
Habchi, J., Chia, S., Galvagnion, C., Michaels, T. C. T., Bellaiche, M. M. J., Ruggeri, F. S., Sanguanini, M., Idini, I., Kumita, J. R., Sparr, E., et al. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0031-x · Cited by 249
Dinkins, M. B., Enasko, J., Hernandez, C. M., Wang, G., Kong, J., Helwa, I., Liu, Y., Terry, A. V., & Bieberich, E. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1429-16.2016 · Cited by 249
Dysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers
Wong, M. W., Braidy, N., Poljak, A., Pickford, R., Thambisetty, M., & Sachdev, P. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.008 · Cited by 223
The multi-tasked life of GM1 ganglioside, a true factotum of nature
Ledeen, R. W., & Wu, G. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.04.005 · Cited by 212
Huynh, T.-P. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075481 · Cited by 210
Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes
Bode, D. C., Baker, M. D., & Viles, J. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.762526 · Cited by 210
Gangliosides of the Vertebrate Nervous System
Schnaar, R. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.020 · Cited by 203
Scala, C. D., Yahi, N., Boutemeur, S., Flores, A., Rodriguez, L., Chahinian, H., & Fantini, J. (2016) · Scientific Reports · doi:10.1038/srep28781 · Cited by 186
Microglia regulate synaptic development and plasticity
Andoh, M., & Koyama, R. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22814 · Cited by 195
Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
Cascella, R., & Cecchi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094914 · Cited by 194
The Toxicity and Polymorphism of β-Amyloid Oligomers
Huang, Y., & Liu, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124477 · Cited by 176
Smith, A. J., & Verkman, A. S. (2017) · The FASEB Journal · doi:10.1096/fj.201700999 · Cited by 162
Cellular cholesterol homeostasis and Alzheimer’s disease
Chang, T.-Y., Yamauchi, Y., Hasan, M. T., & Chang, C. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075630 · Cited by 155
Fabiani, C., & Antollini, S. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00309 · Cited by 158
Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150
Amyloid β oligomers (AβOs) in Alzheimer’s disease
Mroczko, B., Groblewska, M., Litman‐Zawadzka, A., Kornhuber, J., & Lewczuk, P. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1820-x · Cited by 150
Liver Dysfunction as a Novel Player in Alzheimer’s Progression: Looking Outside the Brain
Estrada, L. D., Ahumada, P., Cabrera, D., & Arab, J. P. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00174 · Cited by 144
Evangelisti, E., Cascella, R., Becatti, M., Marrazza, G., Dobson, C. M., Chiti, F., Stefani, M., & Cecchi, C. (2016) · Scientific Reports · doi:10.1038/srep32721 · Cited by 133
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Vieira, M. N. N., Lima‐Filho, R. A. S., & Felice, F. G. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.014 · Cited by 133
The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation
Castellani, R. J., Plascencia‐Villa, G., & Perry, G. L. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0231-z · Cited by 130
APP/Aβ structural diversity and Alzheimer's disease pathogenesis
Roher, A. E., Kokjohn, T. A., Clarke, S. G., Sierks, M. R., Maarouf, C. L., Serrano, G. E., Sabbagh, M., & Beach, T. G. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.007 · Cited by 126
Zuo, L., Hemmelgarn, B. T., Chuang, C., & Best, T. M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/604658 · Cited by 122
Yang, T., O’Malley, T. T., Kanmert, D., Jerecı̀ć, J., Zieske, L. R., Zetterberg, H., Hyman, B. T., Walsh, D. M., & Selkoe, D. J. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0100-y · Cited by 116
Self-citationExosomes as Carriers of Alzheimer's Amyloid-ß
Yuyama, K., & Igarashi, Y. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00229 · Cited by 119
Fatafta, H., Khaled, M., Owen, M. C., Sayyed–Ahmad, A., & Strodel, B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106210118 · Cited by 107
Extracellular Vesicles in Alzheimer’s Disease: Friends or Foes? Focus on Aβ-Vesicle Interaction
Joshi, P., Benussi, L., Furlan, R., Ghidoni, R., & Verderio, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034800 · Cited by 99
Shrivastava, A. N., Aperia, A. C., Melki, R., & Triller, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.026 · Cited by 96
GM1 ganglioside and Alzheimer’s disease
Yanagisawa, K. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9579-5 · Cited by 93
Self-citationAβ–ganglioside interactions in the pathogenesis of Alzheimer's disease
Matsuzaki, K. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183233 · Cited by 82
Salvadores, N., Moreno‐González, I., Gamez, N., Quiroz, G., Vegas‐Gomez, L., Escandón, M., Jiménez, S., Vitórica, J., Gutiérrez, A., Soto, C. A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01332-9 · Cited by 87
Formaldehyde toxicity in age-related neurological dementia
Kou, Y., Zhao, H., Cui, D., Han, H., & Tong, Z. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101512 · Cited by 82
Aβ-oligomers: A potential therapeutic target for Alzheimer's disease
Ghosh, S., Ali, R., & Verma, S. K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124231 · Cited by 79
Geng, H., Pan, Y., Zhang, R., Gao, D. M., Wang, Z., Li, B., Li, N., Guo, D., & Xing, C. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102953 · Cited by 77
Viles, J. H. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202215785 · Cited by 74
Lipids in Amyloid-β Processing, Aggregation, and Toxicity
Morgado, I., & Garvey, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_3 · Cited by 72
Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 71
Oleuropein aglycone and hydroxytyrosol interfere differently with toxic Aβ1-42 aggregation
Leri, M., Natalello, A., Bruzzone, E., Stefani, M., & Bucciantini, M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.015 · Cited by 72
Ganglioside lipids accelerate α-synuclein amyloid formation
Gaspar, R., Pallbo, J., Weininger, U., Linse, S. S., & Sparr, E. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.07.004 · Cited by 68
Alpha-Synuclein and Lipids: The Elephant in the Room?
Sarchione, A., Marchand, A., Taymans, J., & Chartier‐Harlin, M. (2021) · Cells · doi:10.3390/cells10092452 · Cited by 72
Ganglioside GM1 and the Central Nervous System
Guo, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119558 · Cited by 70
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Alzheimer’s Disease Risk Genes and Lipid Regulators
Gaamouch, F. E., Jing, P., Xia, J., & Cai, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160169 · Cited by 67
Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder
Kshirsagar, V., Thingore, C., & Juvekar, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00622-2 · Cited by 66
Dam, D. V., Vermeiren, Y., Dekker, A. D., Naudé, P. J. W., & Deyn, P. P. D. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160502123607 · Cited by 68
Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
Fantini, J., Chahinian, H., & Yahi, N. (2020) · Protein Science · doi:10.1002/pro.3906 · Cited by 63
Cao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
Self-citationTeng, E., Taylor, K. M., Bilousova, T. V., Weiland, D. A., Pham, T., Zuo, X., Yang, F., Chen, P., Glabe, C. G., Takacs, A., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.09.002 · Cited by 65
3D-visualization of amyloid-β oligomer interactions with lipid membranes by cryo-electron tomography
Tian, Y., Liang, R., Kumar, A., Szwedziak, P., & Viles, J. H. (2021) · Chemical Science · doi:10.1039/d0sc06426b · Cited by 59
Michno, W., Wehrli, P. M., Zetterberg, H., Blennow, K., & Hanrieder, J. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.010 · Cited by 60
Yahi, N., & Fantini, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104751 · Cited by 58
Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload
Cascella, R., Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., & Cecchi, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170340 · Cited by 57
Bigi, A., Cascella, R., Chiti, F., & Cecchi, C. (2022) · BioEssays · doi:10.1002/bies.202200086 · Cited by 56
The Role of Lipid Environment in Ganglioside GM1-Induced Amyloid β Aggregation
Rudajev, V., & Novotný, J. (2020) · Membranes · doi:10.3390/membranes10090226 · Cited by 55
Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
Zhang, R., Song, Y., & Su, X. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220809 · Cited by 56
The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer’s Disease
Xia, M., Cheng, X., Yi, R., Gao, D., & Xiong, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8994-0 · Cited by 53
Impact of GM1 on Membrane-Mediated Aggregation/Oligomerization of β-Amyloid: Unifying View
Cebecauer, M., Hof, M., & Amaro, M. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.03.009 · Cited by 51
Pérez‐González, R., Kim, Y., Miller, C., Pacheco‐Quinto, J., Eckman, E. A., & Levy, E. (2020) · The FASEB Journal · doi:10.1096/fj.202000823r · Cited by 57
Comparative Review of Microglia and Monocytes in CNS Phagocytosis
Andoh, M., & Koyama, R. (2021) · Cells · doi:10.3390/cells10102555 · Cited by 55
β-Amyloid Peptide: the Cell Compartment Multi-faceted Interaction in Alzheimer’s Disease
Picone, P., Nuzzo, D., Giacomazza, D., & Carlo, M. D. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00116-9 · Cited by 47
Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
Jeon, Y., Lee, J., Choi, B., Won, S.-Y., & Cho, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030884 · Cited by 46
Extracellular vesicle-associated lipids in central nervous system disorders
Vanherle, S., Haidar, M., Irobi, J., Bogie, J. F. J., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.011 · Cited by 45
Amyloid-β Oligomers: Multiple Moving Targets
Shea, D. W., & Daggett, V. (2022) · Biophysica · doi:10.3390/biophysica2020010 · Cited by 43
Oikawa, N., Matsubara, T., Fukuda, R., Yasumori, H., Hatsuta, H., Murayama, S., Sato, T., Suzuki, A., & Yanagisawa, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121356 · Cited by 44
Self-citationWhat Is the “Relevant” Amyloid β42 Concentration?
Raskatov, J. A. (2019) · ChemBioChem · doi:10.1002/cbic.201900097 · Cited by 47
Li, Y., Tang, H., Zhu, H., Käkinen, A., Wang, D., Andrikopoulos, N., Sun, Y., Nandakumar, A., Kwak, E., Davis, T. P., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c06478 · Cited by 46
Bazrgar, M., Khodabakhsh, P., Prudencio, M., Mohagheghi, F., & Ahmadiani, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105805 · Cited by 45
The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies
Leri, M., Nosi, D., Natalello, A., Porcari, R., Ramazzotti, M., Chiti, F., Bellotti, V., Doglia, S. M., Stefani, M., & Bucciantini, M. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.009 · Cited by 43
Minami, A., Meguro, Y., Ishibashi, S., Ishii, A., Shiratori, M., Sai, S., Horii, Y., Shimizu, H., Fukumoto, H., Shimba, S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764357 · Cited by 42
Fresh evidence for major brain gangliosides as a target for the treatment of Alzheimer's disease
Dukhinova, M., Veremeyko, T., Yung, A. W. Y., Kuznetsova, I. S., Lau, T. Y. B., Kopeikina, E., Chan, A. M.-L., & Ponomarev, E. D. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.020 · Cited by 41
Hirano, W., Sugiyama, E., Hayasaka, T., Ravid, R., Setou, M., & Taki, T. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.033 · Cited by 40
Selivanova, O. M., Surin, A. K., Ryzhykau, Y. L., Glyakina, A. V., Suvorina, M. Y., Kuklin, A. I., Rogachevsky, V. V., & Galzitskaya, O. V. (2018) · Langmuir · doi:10.1021/acs.langmuir.7b03393 · Cited by 40
Lipid rafts and human diseases: why we need to target gangliosides
Fantini, J. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13612 · Cited by 39
Ganglioside-Mediated Assembly of Amyloid β-Protein: Roles in Alzheimer's Disease
Matsuzaki, K., Kato, K., & Yanagisawa, K. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.005 · Cited by 39
Self-citationAttempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases
Sarnataro, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103081 · Cited by 39
Faraji, N., Ebadpour, N., Abavisani, M., & Gorji, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04462-4 · Cited by 37
Graphene quantum dots obstruct the membrane axis of Alzheimer's amyloid beta
Tang, H., Li, Y., Käkinen, A., Andrikopoulos, N., Sun, Y., Kwak, E., Davis, T. P., Ding, F., & Ke, P. C. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp04246g · Cited by 36
Amyloidβ Peptides in interaction with raft-mime model membranes: a neutron reflectivity insight
Rondelli, V., Brocca, P., Motta, S., Messa, M., Colombo, L., Salmona, M., Fragneto, G., Cantú, L., & Favero, E. D. (2016) · Scientific Reports · doi:10.1038/srep20997 · Cited by 33
The significance of sialylation on the pathogenesis of Alzheimer’s disease
Yang, K., Yang, Z., Chen, X., & Li, W. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.009 · Cited by 32
Kawade, N., & Yamanaka, K. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13661 · Cited by 35
Jiménez, S., Navarro, V., Moyano, J., Sanchez-Mico, M. V., Torres, M., Dávila, J. C., Vizuete, M., Gutiérrez, A., & Vitórica, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114041 · Cited by 31
Tokiaki, Y., Yamauchi, Y., Furukawa, K., Ohmi, Y., Ohkawa, Y., Zhang, Q., Okajima, T., & Furukawa, K. (2016) · Scientific Reports · doi:10.1038/srep34505 · Cited by 30
Joshi, P., Gabrielli, M., Ponzoni, L., Pelucchi, S., Stravalaci, M., Beeg, M., Mazzitelli, S., Braida, D., Sala, M., Boda, E., et al. (2017) · Scientific Reports · doi:10.1038/srep41734 · Cited by 31
García‐Viñuales, S., Sciacca, M. F. M., Lanza, V., Santoro, A. M., Grasso, G., Tundo, G. R., Sbardella, D., Coletta, M., Grasso, G., Rosa, C. L., et al. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105072 · Cited by 34
Role of membrane biophysics in Alzheimer's–related cell pathways
Zhu, D., Bungart, B. L., Yang, X., Zhumadilov, Z. S., Lee, J. C., & Askarova, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00186 · Cited by 32
Metadata
- Authors
- Hong, S., Ostaszewski, B. L., Yang, T., O’Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., & Selkoe, D. J.
- Affiliations
- Brigham and Women's Hospital (US)
- University College Dublin (IE)
- National Center for Geriatrics and Gerontology (JP)
- Corresponding author
- Selkoe, Dennis J.
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 82
- Issue
- 2
- Pages
- 308-319
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC4129520
- OpenAlex
- W2052707772
- Cited by
- 213
- References
- 72
- Citations by year
- 2026: 18 · 2025: 11 · 2024: 8 · 2023: 14 · 2022: 21 · 2021: 24 · 2020: 21 · 2019: 14 · 2018: 14 · 2017: 17 · 2016: 21 · 2015: 22 · 2014: 8
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG027443, R01 AG06173, R01AG006173, P01AG036694)
- Yale Center for Clinical Investigation, Yale School of Medicine
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- soluble amyloid-beta oligomers, GM1 ganglioside, brain interstitial fluid, membrane binding, sialic acid, long-term potentiation, hippocampus, Alzheimer's disease, amyloid-beta 42, synaptotoxicity, membrane dysfunction
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Brain, Cell Membrane, Dose-Response Relationship, Drug, Embryo, Mammalian, G(M1) Ganglioside, Gangliosides, Hippocampus, Humans, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Extracellular Fluid, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review